The Institute for Biomedical Innovation (IBI), a new major investment by the University of Cambridge, has launched a survey to help inform the next steps of their journey and better understand how they can support stakeholders.
You can take the survey here and closes on 16th January. The answers will be anonymised, combined, and used to support a structured workshop on the final IBI mission.
Based in the Department of Engineering, the IBI aims to turn early-stage medical technologies into safe, sustainable, clinically ready devices.
It will combine a state-of-the-art prototyping facility equipped for microfabrication, device assembly, and biological testing, with an innovation support programme that guides researchers and companies through sustainability requirements, quality management, clinical trial design, and regulatory approval.
Open to academics, start-ups, and industry partners, the IBI will provide shared laboratories, expert technical staff, and training to speed up the journey from laboratory ideas to real-world healthcare solutions, while also supporting more sustainable manufacturing and better preparedness for future health emergencies.
